Page last updated: 2024-11-02

phenylbutazone and Carcinoma, Bronchogenic

phenylbutazone has been researched along with Carcinoma, Bronchogenic in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
REINHOLD, H1
SAUERBREY, R1

Other Studies

1 other study available for phenylbutazone and Carcinoma, Bronchogenic

ArticleYear
[ON THE TREATMENT OF INOPERABLE BRONCHIAL CARCINOMA].
    Das Deutsche Gesundheitswesen, 1963, Aug-22, Volume: 18

    Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma, Bronchogenic; Neop

1963
chemdatabank.com